Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

NCT06629363 is registered in ClinicalTrials.gov with Centre Hospitalier de PAU as lead sponsor.

NCT NCT06629363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06629363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
Lead sponsor
Centre Hospitalier de PAU
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
April 1, 2036
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant hypertension